共查询到20条相似文献,搜索用时 515 毫秒
1.
《Molecular & cellular proteomics : MCP》2019,18(2):231-244
Highlights
- •OMICS distinguish cancer cells from resistant or cancer stem cells.
- •Bactericidal antibiotics and mitochondria.
- •Linezolid and anticancer therapy.
2.
《Molecular & cellular proteomics : MCP》2019,18(9):1893-1898
Highlights
- •Support for mass spectrometry-based proteomics in cBioPortal.
- •User-friendly web interface, a web API, and an R client to query proteogenomic data.
- •Integration of Clinical Proteomics Tumor Analysis Consortium data with cBioPortal.
3.
《Molecular & cellular proteomics : MCP》2019,18(5):936-953
Highlights
- •In-depth proteome profiling of primary human myeloma cells
- •Characteristics of myeloma cells are related to hypoxic bone marrow conditions
- •Myeloma cells show specific immune evasion strategies
- •Metabolic adaptations involve tumor and stroma cells
4.
《Molecular & cellular proteomics : MCP》2019,18(2):372-382
Highlights
- •Surface loops play an essential role in SH2 domain specificity.
- •Diverse specificities may be obtained from a single SH2 domain by combinatorial mutations in the EF and BG loops.
- •The specificity of a loop mutant correlates with the sequence characteristics of the bait peptide used in its isolation.
5.
《Molecular & cellular proteomics : MCP》2018,17(12):2434-2447
Highlights
- •Anticancer activity of midostaurin but not other PKC inhibitors in NSCLC cells.
- •Mechanism of action by network-based integration of chemo- and phosphoproteomics.
- •Midostaurin polypharmacology by simultaneous inhibition of TBK1, PDPK1 and AURKA.
- •Design of synergistic drug combination with PLK1 inhibitor by pathway validation.
6.
《Molecular & cellular proteomics : MCP》2019,18(6):1255-1268
Highlights
- •The plasma-soluble HLA peptidome of Glioblastoma contains many tumor antigens.
- •This sHLA peptidome may serve as a rich source for disease biomarkers.
- •The sHLA peptidomes are highly correlated with the tumor's membranal HLA peptidomes.
- •The HLA peptidomes differ significantly from the proteomes of the tumors.
7.
《Molecular & cellular proteomics : MCP》2019,18(9):1796-1806
Highlights
- •iTRAQ-based analysis of saliva samples from oral cancer patients.
- •Proteome profiling of saliva samples from patients with oral premalignant lesions.
- •Verification of salivary biomarker candidates with MRM-MS and immunoassays.
- •Identification of salivary proteins as potential biomarkers of oral cancer.
8.
《Molecular & cellular proteomics : MCP》2019,18(4):622-641
Highlights
- •Serial biopsies and autopsy from a metastatic lung cancer patient over 7 years.
- •Tumor heterogeneity characterized by quantifying the proteome and phosphoproteome.
- •Patient-specific database built using whole genome sequencing data from tumors.
- •MRM assay and functional validation of a novel lung-specific CDK12-G879V mutant.
9.
《Molecular & cellular proteomics : MCP》2019,18(3):571-575
Highlights
- •Incrementally build mzML 1.1, and mzIdentML 1.2 files in Python over a file stream.
- •Traverse controlled vocabularies using common mapping patterns.
- •Generate byte offset index as the document streams.
- •Manage referential integrity on-the-fly.
10.
《Molecular & cellular proteomics : MCP》2019,18(12):2516-2523
Highlights
- •Open source software for comprehensive HDX-MS data analysis.
- •Automatic back-exchange correction options.
- •Rigorous statistical analysis of the significance of uptake differences.
- •High quality visualization tools.
11.
《Molecular & cellular proteomics : MCP》2018,17(12):2324-2334
Highlights
- •C9, GSN, PON1, and PON3 validated as serum biomarker candidates of EAC.
- •Multimarker panel with AUROC of 0.93 to aid current endoscopy surveillance of BE.
- •Induction of tissue C9 in BE, dysplastic BE and EAC.
- •Alteration of complement pathway glycoproteins during BE-EAC pathogenesis.
12.
《Molecular & cellular proteomics : MCP》2019,18(4):735-743
Highlights
- •HPV is being introduced as the primary test in cervical cancer screening programs.
- •New biomarkers are needed for co-testing of women HPV positive in screening.
- •Analysis of plasma from women with invasive cervical cancer identified a 11-marker panel.
- •This signature shows high sensitivity and specificity to identify women with cancer.
13.
《Molecular & cellular proteomics : MCP》2019,18(5):865-875
Highlights
- •Microvesicle proteomics of 187 utero-tubal lavage samples for early diagnosis of HGOC.
- •Machine learning-based classification of a 9-protein signature with high predictive power.
- •Signature has 70‥ sensitivity and 76.2‥ specificity, predicting stage I lesions.
14.
《Molecular & cellular proteomics : MCP》2019,18(1):151-161
Highlights
- •New MALDI MS imaging sample preparation workflow reveals tissue protease activity.
- •Differential time- and inhibitor concentration-dependence confirm active proteases.
- •Mouse gastric tumor displays high protease activity compared to surrounding tissue.
- •Proteomic data and biochemical protease activity assay support MALDI MSI results.
15.
《Molecular & cellular proteomics : MCP》2019,18(2):245-262
Highlights
- •AP-DIA/SWATH analysis to identify TCTP-interacting proteins in NF1 tumor cells.
- •A highly specific TCTP–EF1A2 interaction but rather than TCTP–EF1A1 interaction.
- •TCTP–EF1A2 interaction mediating formation of EF1A2-elogation factor complex.
- •TCTP–EF1A2 dependent translation machinery regulating NF1 tumor cell growth.
16.
《Molecular & cellular proteomics : MCP》2019,18(7):1410-1427
Highlights
- •Quantitative (phoshpo)proteome of primary cell cultures of patient-matched prostate CAF and NPF.
- •Key CAF-associated proteins validated using orthogonal methodologies.
- •LOXL2 inhibitors D-penicillamine and PXS-S2A impaired CAF migration and ECM alignment.
- •Pre-treatment with LOXL2 inhibitors impaired migratory capacity of RWPE-2 cells in co-culture.
17.
《Molecular & cellular proteomics : MCP》2018,17(11):2270-2283
Highlights
- •Gene-centric inference algorithm with classification for distinguishable groups.
- •Shared peptides are split proportionally to corresponding unique peptide ratios.
- •iBAQ values are calculated for label-free, isotopic or isobaric labeling methods.
- •Universally handles single or mixed species PDX data with accurate deconvolution.
18.
《Molecular & cellular proteomics : MCP》2019,18(4):669-685
Highlights
- •quantitative phosphoproteome analysis of TDM-activated macrophages.
- •distinct Mincle-dependent and independent phosphorylation and gene regulations.
- •Mincle-dependent activation of PI3K/AKT signaling by TDM.
- •Mincle-independent macrophage response is linked to cell cycle regulation.
19.
《Molecular & cellular proteomics : MCP》2019,18(9):1836-1850
Highlights
- •Rigorous experimental design and data analysis for large-scale SRM studies.
- •Plasma-based biomarker signature combined with CA125 for ovarian cancer detection.
- •Broadly applicable strategy for the development of diagnostic biomarker assays.
20.
《Molecular & cellular proteomics : MCP》2019,18(12):2348-2358
Highlights
- •Glycosylation is not currently considered in flu vaccine design.
- •Glycosylation influences on immunodominance are not well understood.
- •Identification of site-specific glycosylation using mass spectrometry has matured.
- •New methods are needed to quantify site-specific glycosylation for vaccine design.